本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ARS PHARMACEUTICALS INC

17.37
+0.85235.16%
成交量:96.83万
成交额:1,687.16万
市值:17.06亿
市盈率:-108.04
高:17.90
开:16.58
低:16.44
收:16.52
数据加载中...
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/03/29

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/21

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report
2023/09/26

重要事件披露

Form 8-K - Current report
2023/09/25

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/20

重要事件披露

Form 8-K - Current report
2023/09/02

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/01

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/10

重要事件披露

Form 8-K - Current report
2023/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities